Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cameron

Showing results (351-360 of 481) with videos related to

Pageof 49
Sort By:
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 2, 2018
Effect of dietary arachidonic acid supplementation on acute muscle adaptive responses to resistance exercise in trained men: a randomized controlled trialCameron J Mitchell, Randall F D'Souza, Vandre C Figueiredo, et al.
The Lancet. Oncology|July 19, 2014
Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trialRobert Coleman, David Cameron, David Dodwell, et al.
Journal of the National Cancer Institute|February 10, 2018
Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) TrialJanet Brown, Emma Rathbone, Samantha Hinsley, et al.
Pharmacoepidemiology and Drug Safety|April 22, 2020
Use of record linkage to evaluate treatment outcomes and trial eligibility in a real-world metastatic prostate cancer population in ScotlandKelly Baillie, Tanja Mueller, Jiafeng Pan, et al.
British Journal of Cancer|February 12, 2024
Germline predictors for bevacizumab induced hypertensive crisis in ECOG-ACRIN 5103 and BEATRICEFei Shen, Guanglong Jiang, Santosh Philips, et al.
Brain Sciences|September 28, 2024
Increased Risk for Clinically Significant Sleep Disturbances in Mild Traumatic Brain Injury: An Approach to Leveraging the Federal Interagency Traumatic Brain Injury Research DatabaseMaya E O'Neil, Danielle Krushnic, William C Walker, et al.
Journal of the National Cancer Institute|April 4, 2026
The benefit of adjuvant pertuzumab and trastuzumab according to estrogen receptor and HER2 expression: a Sub-analysis of the APHINITY trialElisa Agostinetto, Gabriella Gentile, Faye Samy, et al.
Frontiers in Endocrinology|June 21, 2021
Inhibition of the Renin-Angiotensin System Reduces Gene Expression of Inflammatory Mediators in Adipose Tissue Independent of Energy BalanceCaitlin S Mitchell, Shirmila D Premaratna, Garth Bennett, et al.
Nutrition Research (New York, N.Y.)|November 26, 2009
Green tea, black tea, and epigallocatechin modify body composition, improve glucose tolerance, and differentially alter metabolic gene expression in rats fed a high-fat dietNora Chen, Rebecca Bezzina, Edward Hinch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2013
Osteonecrosis of the jaw and oral health-related quality of life after adjuvant zoledronic acid: an adjuvant zoledronic acid to reduce recurrence trial subprotocol (BIG01/04)Emma J Rathbone, Janet E Brown, Helen C Marshall, et al.
Pageof 49

Showing results (351-360 of 481) with videos related to

Sort By:
Pageof 49
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 2, 2018
Effect of dietary arachidonic acid supplementation on acute muscle adaptive responses to resistance exercise in trained men: a randomized controlled trialCameron J Mitchell, Randall F D'Souza, Vandre C Figueiredo, et al.
The Lancet. Oncology|July 19, 2014
Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trialRobert Coleman, David Cameron, David Dodwell, et al.
Journal of the National Cancer Institute|February 10, 2018
Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) TrialJanet Brown, Emma Rathbone, Samantha Hinsley, et al.
Pharmacoepidemiology and Drug Safety|April 22, 2020
Use of record linkage to evaluate treatment outcomes and trial eligibility in a real-world metastatic prostate cancer population in ScotlandKelly Baillie, Tanja Mueller, Jiafeng Pan, et al.
British Journal of Cancer|February 12, 2024
Germline predictors for bevacizumab induced hypertensive crisis in ECOG-ACRIN 5103 and BEATRICEFei Shen, Guanglong Jiang, Santosh Philips, et al.
Brain Sciences|September 28, 2024
Increased Risk for Clinically Significant Sleep Disturbances in Mild Traumatic Brain Injury: An Approach to Leveraging the Federal Interagency Traumatic Brain Injury Research DatabaseMaya E O'Neil, Danielle Krushnic, William C Walker, et al.
Journal of the National Cancer Institute|April 4, 2026
The benefit of adjuvant pertuzumab and trastuzumab according to estrogen receptor and HER2 expression: a Sub-analysis of the APHINITY trialElisa Agostinetto, Gabriella Gentile, Faye Samy, et al.
Frontiers in Endocrinology|June 21, 2021
Inhibition of the Renin-Angiotensin System Reduces Gene Expression of Inflammatory Mediators in Adipose Tissue Independent of Energy BalanceCaitlin S Mitchell, Shirmila D Premaratna, Garth Bennett, et al.
Nutrition Research (New York, N.Y.)|November 26, 2009
Green tea, black tea, and epigallocatechin modify body composition, improve glucose tolerance, and differentially alter metabolic gene expression in rats fed a high-fat dietNora Chen, Rebecca Bezzina, Edward Hinch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2013
Osteonecrosis of the jaw and oral health-related quality of life after adjuvant zoledronic acid: an adjuvant zoledronic acid to reduce recurrence trial subprotocol (BIG01/04)Emma J Rathbone, Janet E Brown, Helen C Marshall, et al.
Pageof 49